Maxime Meylan

Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer

Maxime Meylan, Florent Petitprez, Étienne Becht et al. · Immunity · 2022 · 771 citations

Medicine, Immunology, Oncology +13

B cells and cancer: To B or not to B?

Wolf H. Fridman, Florent Petitprez, Maxime Meylan et al. · The Journal of Experimental Medicine · 2020 · 193 citations · Full text

Life Sciences, Immunology, Oncology +17

The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression

Florent Petitprez, Sacha Lévy, Cheng‐Ming Sun et al. · Genome Medicine · 2020 · 154 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial

Yann Vano, Réza Elaidi, Mostefa Bennamoun et al. · The Lancet Oncology · 2022 · 136 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy

Kirsten A. White, Kate Connor, Maxime Meylan et al. · Annals of Oncology · 2022 · 125 citations · Full text

Medicine, Cancer Biology, Oncology +17